Cite
MLA Citation
E. Tamburini et al.. “2109 Anti-EGFR or Bevacizumab in first line treatment of RAS wild type metastatic colorectal neoplasm (RwtMCRC): pooled analysis of randomized clincal trials.” European journal of cancer, vol. 51, n.d., pp. S365–. http://access.bl.uk/ark:/81055/vdc_100030628213.0x000025